Page 966 - Cardiac Nursing

AM
p94
ra
09
10
:37
pta
g
a
P
2 A
94
e
/
0-i
nd_
1-9
LWBK340-ind_p941-958.qxd 7/1/09 10:37 AM Page 942 Aptara
LWB
K34
58.
qxd
7
/
1
942 Index
!NALGESIA REGURGITATION OF T MALIGNANT ELECTRICAL THERAPY FOR n
ANGIOTENSIN CONVERTING ENZYME INHIBITORS STENOSIS OF 3EE !ORTIC STENOSIS MECHANISMS OF
)6 MORPHINE SULFATE !ORTIC ANEURYSM T ABNORMAL IMPULSE CONDUCTION n
ORAL n !ORTIC STENOSIS ABNORMAL IMPULSE INITIATION n
!NATOMIC REENTRY F CAUSE OF METOPROLOL T

!NEROID MANOMETERS CLINICAL MANIFESTATIONS MEXILETINE T
!NGINA D DIAGNOSTIC TEST OF n IN MYOCARDIAL INFARCTION
CHEST PAIN IN MEDICAL MANAGEMENT PROCAINAMIDE T
AND DYSPNEA SCALE D PATHOLOGY OF PROPAFENONE T
IN (26 PATHOPHYSIOLOGY OF PROPRANOLOL T
FOR MYOCARDIAL )SCHEMIA PHYSICAL ASSESSMENT OF QUINIDINE T
IN SLEEP SURGICAL MANAGEMENT n RECOMMENDED ENERGY LEVELS OF D
STABLE CLASSIC !ORTIC VALVE SINUS ARREST

UNSTABLE F REGURGITATION SOTALOL T
!NGIOGRAPHIC CONTRAST AGENTS CAUSE OF AND SUDDEN DEATH n
!NGIOJET CLINICAL MANIFESTATIONS SUPRAVENTRICULAR T
!NGIOTENSIN CONVERTING ENZYME !#% DIAGNOSTIC TESTS VENTRICULAR T
n PATHOLOGY !RRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
D
D
!NION GAP D n PHYSICAL ASSESSMENT !26#
F
F
F

!NISOTROPIC REENTRY PHYSICAL EXAMINATIONS !RTERIAL BARORECEPTORS F F
F
!NTIDORMIC RECIPROCATING TACHYCARDIA REPLACEMENT OF !RTERIAL BLOOD GASES
!NTERIOR HEMIBLOCK 3EE ,EFT !NTERIOR &ASCICULAR STENOSIS FOR ACIDnBASE STATUS n
"LOCK ,!&" CAUSE OF MEASUREMENT OF
!NTIARRHYTHMIC DRUGS CLASSIFICATION O T CLINICAL MANIFESTATIONS OF !RTERIAL CATHETERIZATION T
!NTIARRHYTHMIC THERAPY DIAGNOSTIC TEST OF n !RTERIAL CIRCULATION
D MEDICAL MANAGEMENT !RTERIAL HYPOXEMIA
!NTICOAGULANT AGENTS PATHOLOGY OF !RTERIAL OXYGEN CONTENT #A/ n
T
T
DIRECT THROMBIN INHIBITORS PATHOPHYSIOLOGY OF T F

&ONDAPARINUX PHYSICAL ASSESSMENT OF !RTERIAL OXYGEN SATURATION 3A/
5&( AND ,OW -OLECULAR 7EIGHT (EPARIN SURGICAL MANAGEMENT OF n
n !ORTIC VALVE REPLACEMENT !62 !RTERIAL PRESSURE F

!NTICOAGULATION !PEX IMPULSE ARTERIAL BARORECEPTORS ROLE TO DECREASE
ATRIAL FIBRILLATION ASSESSMENT OF COMPLICATIONS OF
CLOTTING DISORDERS IN CHEST WALL VS CUFF PRESSURE n
DEFINITION !PICAL BALLOON SYNDROME D INDICATION n
DRUG INDUCED !POLIPOPROTEIN % APO% INTERPRETATION OF

DRUGS USED TO PROMOTE D !POPROTEIN WAVE n F

F
OPTIONS FOR 0#) !RGININE 6ASOPRESSIN !60 n F T T T !RTERIAL PRESSURE WAVE n F

F
F
F
Y
Y
TO SUPPORT REPERFUSION THERAPY F !RTERIAL THROMBOSIS

!NTIDEPRESSANTS !ROUSAL STATE !RTERIOLES F
FOR HEART RATE CONTROL T !RRHYTHMIAS !RTERIOVENOUS !6 FISTULA
FOR SLEEP PROMOTION !0 MEDIATED D !RTERY IES
!NTIDIURETIC HORMONE !$( ATENOLOL IN T AREA SUPPLIED BY T
FOR BLOOD PRESSURE CONTROL n ATRIAL BLOOD VOLUME OF F

DEFINITION ATROPINE IN T CIRCUMFLEX OF
IN KIDNEY REGULATION T BLOOD PRESSURE MEASUREMENT n CIRCUMFLEX BRANCH OF
!NTIISCHEMIC THERAPIES COMPLEX VASCULAR RESISTANCE OF

BETA ADRENERGIC BLOCKERS n !6 DISSOCIATION n Fn F !SPARTATE AMINOTRANSFERASE !34 F T
T
F

F
F
F
T
CALCIUM CHANNEL BLOCKERS DIFFERENTIAL DIAGNOSIS OF n

NITRATES PREEXCITATION SYNDROMES n F !SPIRATION THROMBECTOMY
T
T
!NTIPLATELET SUPRAVENTRICULAR TACHYCARDIA n !SYSTOLE T
ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS VENTRICULAR TACHYCARDIA n !TEPLASE
ASPIRIN CONDUCTION ABNORMALITIES n !THEROGENESIS
)6 ANTIPLATELET AGENTS n IN CONDUCTION BLOCKS 3EE #ONDUCTION BLOCKS !THEROSCLEROSIS n

!NTITACHYCARDIA PACING F CONDUCTION DISTURBANCES GENETIC ASPECTS DISSECTION OF n
!NTITHYMOCYTE PREPARATIONS AND CONDUCTION DISTURBANCES !THEROSCLEROTIC LESIONS

!NXIETY F DECREASED CARDIAC OUTPUT RELATED TO ANEURYSMS IN
IN CORONARY HEART DISEASE DEFINITION OF COMPONENTS OF
AND DEPRESSION DIGOXIN IN T CALCIUM
DIAGNOSIS OF DILTIAZEM IN T COLLAGEN
GOALS OF n DISOPYRAMIDE FOR T ELASTIN
KNOWLEDGE DEFICIT IN DOFETILIDE FOR T FIBRINOGEN T
AN QUALITY OF LIFE n ELECTRICAL THERAPY OF n LIPID IN
F
F
RELATED TO UNCERTAINTY ENERGY LEVELS OF D LIPOPROTEIN IN
AND RELAXATION THERAPY EPINEPHRINE FOR T LYMPHOCYTES
SCREENING FOR n T ESMOLOL T MACROPHAGES
!ORTA DURING EXERCISE TESTING n PROTEOGLYCANS
BALLOON PUMP FOR 3EE )NTRA AORTIC BALLOON FLECAINIDE T SMOOTH MUSCLE CELLS IN
PUMP )!"0 FOCAL TREATMENT OF T HUMAN T
COARCTATION OF n F IBUTILIDE T TYPE )) n T

CLINICAL MANIFESTATION OF LIDOCAINE T TYPE ))) T
DESCRIPTION OF LONG TERM THERAPY OF ACCESSORY PATHWAY TYPE ) INITIAL T
MANAGEMENT OF n MEDIATED TYPE )6 n T
PATHOPHYSIOLOGY OF MAGNESIUM FOR T TYPE 6 T